Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) has transformed weight management for millions of people worldwide. Originally approved by the FDA for blood sugar control in 2017, clinical trials later revealed its powerful appetite-suppressing effects, leading to its approval for chronic weight management in 2021. PlexusDx offers compounded semaglutide injections starting at $149 per month, making this therapy accessible without insurance requirements.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors in your brain, pancreas, and digestive tract. This activation signals fullness to your hypothalamus—the brain region controlling hunger and satiety—reducing your desire to eat at each meal. The medication also slows gastric emptying, meaning food stays in your stomach longer, extending that feeling of satisfaction between meals.
Beyond appetite reduction, semaglutide improves insulin sensitivity and helps regulate blood sugar levels. This dual action reduces cravings for high-calorie foods and stabilizes energy throughout the day, making it easier to stick to a calorie deficit without constant hunger. Studies show participants using semaglutide consume approximately 400–500 fewer calories daily without conscious restriction.
Clinical Evidence Supporting Semaglutide Weight Loss
The STEP clinical trials demonstrated semaglutide's effectiveness across four separate studies involving over 4,500 participants. In STEP 1, patients on semaglutide 2.4 mg weekly lost an average of 15% of their body weight over 68 weeks, compared to 2.6% in the placebo group. STEP 3 and STEP 4 showed similarly impressive results in participants with established cardiovascular disease or high cardiometabolic risk.
Real-world data from clinical practices confirm these findings. Patients typically experience initial weight loss within 4–8 weeks, with the most significant reductions occurring between months 3–6 of treatment. Long-term studies show that weight loss is sustained when individuals continue the medication, with many maintaining 12–15% reductions after two years of consistent use.
Semaglutide Injection vs. Oral Tablets: Which Delivery Method Works Better
PlexusDx offers both compounded semaglutide injections and oral tablets, each with distinct advantages. Injections deliver medication directly into subcutaneous tissue, bypassing the digestive system and ensuring consistent weekly absorption. Injections typically show faster onset of appetite reduction and more predictable dose response, with most patients reaching therapeutic levels within 2–3 weeks.
Oral semaglutide requires higher doses due to incomplete intestinal absorption, and it must be taken on an empty stomach for maximum effectiveness. However, oral formulations appeal to patients who prefer pill-based therapy or have needle anxiety. PlexusDx compounded semaglutide injections start at $149 per month, while oral options begin at $249 per month—your dose may need to go up, but your price won't change across commitment tiers.
Side Effects and Safety Considerations for Semaglutide
The most common side effects are gastrointestinal and typically mild: nausea, vomiting, diarrhea, and constipation. These effects occur in 25–40% of users, peak during the first 2–4 weeks, and usually resolve as your body adjusts to the medication. Drinking plenty of water, eating smaller meals, and avoiding high-fat foods can minimize GI discomfort during the titration phase.
Serious adverse events are rare when semaglutide is used appropriately. The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2. PlexusDx providers review your complete medical history and current medications before starting therapy to ensure safety. If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis, contact your healthcare provider immediately.
Personalized Weight Loss: How Genetic Testing Improves Semaglutide Outcomes
Not everyone responds identically to semaglutide because genetic variations influence how your body processes appetite-regulating peptides. PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 metabolic pathways and 49 peptides, including key variants like GLP1R rs6923761 and FTO rs9939609. These insights reveal whether your body naturally produces fewer GLP-1 receptors or has reduced sensitivity to satiety signals.
By understanding your peptide pathways, PlexusDx providers personalize your starting dose, titration schedule, and medication choice. Some patients respond rapidly to standard semaglutide doses, while others benefit from combination therapies like GLP-Squared (semaglutide plus tirzepatide) available from PlexusDx. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, helping optimize your weight loss protocol based on your unique biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is semaglutide (Ozempic) approved by the FDA for weight loss?
Yes, the FDA approved semaglutide under the brand name Wegovy in 2021 specifically for chronic weight management in adults with obesity or overweight with weight-related conditions. Ozempic is the FDA-approved formulation for type 2 diabetes, though doctors often prescribe it off-label for weight loss. PlexusDx offers compounded semaglutide from licensed 503A compounding pharmacies, which are not FDA-approved but meet strict USP standards for purity and potency.
How much weight can I expect to lose with semaglutide?
Clinical trials show an average weight loss of 15% of body weight over 68 weeks, though individual results vary. Some patients lose 10–12%, while others achieve 18–22% reductions. Weight loss typically accelerates between months 2–6 and plateaus around month 6–8 if dosing remains constant. Your genetics, diet quality, physical activity, and baseline metabolic rate all influence your individual outcome.
How much does semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month across three commitment tiers—your dose may need to go up, but your price won't. No insurance is required, and treatment is HSA/FSA eligible. Oral semaglutide begins at $249 per month. All medications come from licensed 503A compounding pharmacies and are available in all 50 states.
Are there serious side effects I should know about before starting semaglutide?
Most side effects are mild gastrointestinal symptoms (nausea, constipation, diarrhea) that resolve within 2–4 weeks. Serious complications are rare but include pancreatitis symptoms (severe abdominal pain), thyroid concerns (if you have family history of medullary thyroid cancer), and dehydration-related complications. PlexusDx providers screen your medical history thoroughly before starting therapy to identify contraindications and ensure safe use.
Will the PlexusDx Precision Peptide Genetic Test help me lose more weight on semaglutide?
Yes—the Precision Peptide Genetic Test ($99 after your first month) identifies variants in your GLP1R, FTO, MC4R, and GIPR genes that influence how your body responds to appetite-suppressing medications. These insights help PlexusDx providers optimize your starting dose, titration speed, and medication choice, maximizing weight loss while minimizing side effects based on your unique peptide pathways.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding How Long People Usually Take Ozempic for Health and Weight Management
Is Mounjaro More Expensive Than Ozempic?